Beta Drugs (India) Price History

BETA Stock   1,856  54.30  2.84%   
Below is the normalized historical share price chart for Beta Drugs extending back to October 12, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Beta Drugs stands at 1,856, as last reported on the 26th of January, with the highest price reaching 1,902 and the lowest price hitting 1,841 during the day.
 
Covid
If you're considering investing in Beta Stock, it is important to understand the factors that can impact its price. Currently, Beta Drugs is very steady. Beta Drugs secures Sharpe Ratio (or Efficiency) of 0.0307, which signifies that the company had a 0.0307 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Beta Drugs, which you can use to evaluate the volatility of the firm. Please confirm Beta Drugs' Risk Adjusted Performance of 0.0314, mean deviation of 2.44, and Downside Deviation of 3.34 to double-check if the risk estimate we provide is consistent with the expected return of 0.0938%.
  
Beta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0307

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskBETAHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.06
  actual daily
27
73% of assets are more volatile

Expected Return

 0.09
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average Beta Drugs is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beta Drugs by adding it to a well-diversified portfolio.

Beta Drugs Stock Price History Chart

There are several ways to analyze Beta Stock price data. The simplest method is using a basic Beta candlestick price chart, which shows Beta Drugs price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 10, 20242251.75
Lowest PriceJanuary 13, 20251779.3

Beta Drugs January 26, 2025 Stock Price Synopsis

Various analyses of Beta Drugs' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Beta Stock. It can be used to describe the percentage change in the price of Beta Drugs from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Beta Stock.
Beta Drugs Price Daily Balance Of Power(0.90)
Beta Drugs Price Rate Of Daily Change 0.97 
Beta Drugs Price Action Indicator(42.85)

Beta Drugs January 26, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Beta Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Beta Drugs intraday prices and daily technical indicators to check the level of noise trading in Beta Stock and then apply it to test your longer-term investment strategies against Beta.

Beta Stock Price History Data

The price series of Beta Drugs for the period between Mon, Oct 28, 2024 and Sun, Jan 26, 2025 has a statistical range of 569.4 with a coefficient of variation of 7.34. The prices are distributed with arithmetic mean of 2022.04. The median price for the last 90 days is 2015.0.
OpenHighLowCloseVolume
01/26/2025
 1,860  1,902  1,841  1,856 
01/24/2025 1,860  1,902  1,841  1,856  1,800 
01/23/2025 1,890  1,950  1,870  1,910  4,900 
01/22/2025 1,900  1,903  1,850  1,875  3,300 
01/21/2025 1,941  1,950  1,895  1,895  2,000 
01/20/2025 1,890  1,920  1,850  1,905  2,900 
01/17/2025 1,927  1,927  1,855  1,890  1,500 
01/16/2025 1,920  1,940  1,912  1,927  1,100 
01/15/2025 1,816  1,936  1,816  1,900  3,200 
01/14/2025 1,838  1,875  1,800  1,827  5,800 
01/13/2025 1,970  1,970  1,774  1,779  11,300 
01/10/2025 2,010  2,010  1,961  1,977  3,400 
01/09/2025 2,050  2,070  2,010  2,012  1,400 
01/08/2025 2,010  2,090  2,000  2,076  3,100 
01/07/2025 2,039  2,075  1,970  2,043  2,000 
01/06/2025 2,055  2,072  1,991  1,998  3,500 
01/03/2025 1,960  2,069  1,960  2,055  4,600 
01/02/2025 1,980  1,993  1,943  1,965  3,900 
12/31/2024 1,990  2,020  1,977  2,009  1,900 
12/30/2024 2,132  2,132  1,985  1,990  5,300 
12/27/2024 2,080  2,148  2,041  2,072  4,700 
12/26/2024 1,995  2,089  1,975  2,020  9,000 
12/24/2024 2,010  2,045  1,910  1,949  7,200 
12/23/2024 2,060  2,080  2,000  2,017  5,000 
12/20/2024 2,127  2,127  2,051  2,060  2,800 
12/19/2024 2,153  2,153  2,095  2,127  2,700 
12/18/2024 2,083  2,125  2,020  2,124  1,800 
12/17/2024 2,068  2,125  2,050  2,124  3,200 
12/16/2024 2,171  2,211  2,061  2,086  6,900 
12/13/2024 2,160  2,200  2,111  2,171  5,000 
12/12/2024 2,270  2,280  2,160  2,199  6,800 
12/11/2024 2,252  2,278  2,229  2,235  1,300 
12/10/2024 2,251  2,300  2,220  2,252  6,300 
12/09/2024 2,190  2,228  2,135  2,222  5,300 
12/06/2024 2,240  2,273  2,196  2,198  6,400 
12/05/2024 2,215  2,266  2,215  2,243  5,900 
12/04/2024 2,258  2,258  2,216  2,241  1,900 
12/03/2024 2,240  2,248  2,200  2,242  5,400 
12/02/2024 2,226  2,255  2,150  2,200  10,200 
11/29/2024 2,150  2,200  2,122  2,172  4,500 
11/28/2024 2,270  2,295  2,120  2,143  10,900 
11/27/2024 2,192  2,255  2,175  2,247  8,900 
11/26/2024 2,144  2,195  2,135  2,192  5,000 
11/25/2024 2,111  2,260  2,111  2,173  4,300 
11/22/2024 1,983  2,109  1,983  2,085  5,800 
11/21/2024 2,016  2,027  1,931  1,983  4,000 
11/19/2024 1,988  2,035  1,988  2,015  4,700 
11/18/2024 2,037  2,037  1,981  2,003  4,100 
11/14/2024 1,990  2,063  1,990  2,047  4,400 
11/13/2024 2,050  2,106  2,000  2,015  5,600 
11/12/2024 2,178  2,278  2,050  2,071  14,700 
11/11/2024 2,208  2,326  2,122  2,178  21,900 
11/08/2024 2,185  2,209  2,085  2,194  14,400 
11/07/2024 2,085  2,179  2,070  2,160  26,800 
11/06/2024 1,947  1,988  1,931  1,984  7,700 
11/05/2024 2,010  2,088  1,921  1,944  13,600 
11/04/2024 2,000  2,009  1,950  1,981  9,100 
11/01/2024 1,949  1,980  1,949  1,971  3,500 
10/31/2024 2,000  2,000  1,902  1,917  2,400 
10/30/2024 1,870  1,964  1,862  1,909  7,400 
10/29/2024 1,784  1,950  1,731  1,943  8,100 

About Beta Drugs Stock history

Beta Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Beta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Beta Drugs will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Beta Drugs stock prices may prove useful in developing a viable investing in Beta Drugs

Beta Drugs Stock Technical Analysis

Beta Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Beta Drugs technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Beta Drugs trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

Beta Drugs Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Beta Drugs' price direction in advance. Along with the technical and fundamental analysis of Beta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Beta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Beta Stock Analysis

When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.